So it is challenging but greatly significant to explore the underlying molecular mechanism about why LSM5 and LSM8 could be potential biomarkers for chemoresistant GC patients, we firstly analyzed the GO enrichment and KEGG annotation in GC. This evidence concerns the gene LSM8 and gastric cancer.